Ms. Masayo Takahashi implemented the first case of transplant using the retinal cells induced from iPS cells. She told us about her struggles and inspirations found at the frontier of regenerative medicine. If we can distinguish what we can change and cannot change, and have the courage to change the situation, then we will be able to change the society.
After serving as an assistant at Kyoto University Hospital, she became a researcher at the Salk Institute for Biological Studies in 1955, where she found potential of using stem cells for retina treatment. In August 2013, she started a clinical study using autologous induced pluripotent stem cells (iPSCs) to treat exudative age-related macular degeneration, and performed the world’s first case of implantation in September 2014. She is now the project leader at the Laboratory for Retinal Regeneration Research in RIKEN Center for Developmental Biology. She specializes in retinal degeneration, macular affection, regenerative therapy and low-vision care. Apart from her research, she has launched the “isee!” movement to transform the public image of the visually challenged. She established NEXT VISION in 2014 and assumed its director in 2016, with the vision “to help the supported to support others”.
This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx